Dossenheim, Germany

Christoph Rosli

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Dossenheim, DE (2012 - 2015)
  • Deisenhofen, DE (2018)

Company Filing History:


Years Active: 2012-2018

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Work of Christoph Rosli in Targeting Tumor Metastases

Introduction: Christoph Rosli, a talented inventor based in Dossenheim, Germany, has made significant strides in the field of oncology with his groundbreaking patents. With four patents to his name, Rosli's latest inventions focus on targeting specific antigens associated with tumor metastases for more effective treatment options.

Latest Patents:

1. "Antigen associated with the neovasculature of tumour metastases" - Rosli's invention centers around a binding member that targets the Extra Domain-A (ED-A) isoform of fibronectin. This innovative approach holds great promise in the treatment of tumor metastases by specifically targeting the neovasculature associated with cancer spread.

2. "Antigen associated with the neovasculature of tumour metastases" - This patent further underscores Rosli's dedication to developing novel strategies for combating tumor metastases through precise targeting of critical antigens within the neovasculature.

Career Highlights: Christoph Rosli is currently affiliated with Philogen S.p.A., a prominent biotechnology company known for its cutting-edge research and development initiatives in the field of oncology. His role at Philogen S.p.A. allows him to leverage his expertise in molecular biology and oncology to push the boundaries of therapeutic innovation.

Collaborations: In his professional journey, Rosli has collaborated closely with esteemed colleagues such as Alessandra Villa and Giovanni Neri. Together, they have spearheaded research projects aimed at revolutionizing cancer treatment methodologies and improving patient outcomes.

Conclusion: Christoph Rosli's innovative contributions to the field of oncology, particularly in the realm of targeting tumor metastases, stand as a testament to his passion for advancing medical science. Through his relentless pursuit of novel solutions and strategic collaborations, Rosli continues to pave the way for enhanced treatment modalities in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…